Advanced search in Projects
Filters
Active within
Funder (13)
Start Year (25)
End Year (1)
Clear
Filters
Active within
Funder (13)
Start Year (25)
End Year (1)
Clear
Loading
- project . 2019 - 2024Funder: NIH Project Code: 1R01CA225792-01A1Partners: DARTMOUTH-HITCHCOCK CLINIC
- project . 2020 - 2024Funder: UKRI Project Code: MR/S021620/1Partners: University of Cambridge
- project . 2020 - 2024Funder: UKRI Project Code: 2445411Partners: NTU
- project . 2018 - 2024Funder: FCT Project Code: DL 57/2016/CP1377/CT0017Funder Contribution: 114,154 EURPartners: UMINHO
- project . 2020 - 2024Funder: UKRI Project Code: 2417301Partners: University of London
- project . 2021 - 2024Funder: EC Project Code: 963540Overall Budget: 11,703,400 EURFunder Contribution: 9,888,800 EUROpen Access mandate for Publications and Research DataPartners: EURECAT, ASAS, ICCS, POWERTECH, TES RECUPYL SAS, TRIAD, CRF, IREC, A AGRATI SPA, SINTEF...
With the goal of accelerating the mass market take-up of ultra-high-performance batteries for battery electric vehicles (BEV) and plug-in hybrids (PHEV), MARBEL will base its approaches, solutions and innovations around the versatility concept as an axis within the enti...
- project . 2017 - 2024Funder: UKRI Project Code: ST/P006744/1Partners: Durham University
- project . 2021 - 2024Funder: EC Project Code: 101030608Overall Budget: 263,732 EURFunder Contribution: 263,732 EUROpen Access mandate for Publications and Research DataPartners: IDIBAPS, UNIPV
Mood disorders (MDs) affect more than 300 million people. They are the third leading causes in 2017 of years lived with disability. Currently, pharmacotherapy represents the first-line option, but growing evidence suggests that although it is effective in the treatment ...
- project . 2021 - 2024Funder: UKRI Project Code: EP/W522442/1Partners: University of St Andrews
- project . 2022 - 2024Funder: EC Project Code: 101023887Overall Budget: 212,934 EURFunder Contribution: 212,934 EUROpen Access mandate for Publications and Research DataPartners: THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Finding a non-aggressive treatment against Cancer is one of the most important challenges that medicine has nowadays. Immunotherapy has emerged as one of the best options to overcome the current problems of chemotherapy. By the use of monoclonal antibodies (mAb), immuno...